Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial

Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) Study Group

Research output: Contribution to journalArticle


In a large community-randomized trial, biannual azithromycin distributions significantly reduced postneonatal childhood mortality in sub-Saharan African sites. Here, we present a prespecified secondary analysis showing that much of the protective effect was in the first 3 months postdistribution. Distributing more frequently than biannually could be considered if logistically feasible. Clinical Trials Registration. NCT02047981.

Original languageEnglish (US)
Pages (from-to)2114-2116
Number of pages3
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Issue number12
Publication statusPublished - May 30 2019



  • azithromycin
  • childhood mortality
  • sub-Saharan Africa

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this